GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FDC Ltd (NSE:FDC) » Definitions » 3-Year Revenue Growth Rate

FDC (NSE:FDC) 3-Year Revenue Growth Rate : 15.00% (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is FDC 3-Year Revenue Growth Rate?

FDC's Revenue per Share for the three months ended in Mar. 2024 was ₹27.47.

During the past 12 months, FDC's average Revenue per Share Growth Rate was 10.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 15.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 13.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of FDC was 19.00% per year. The lowest was 3.80% per year. And the median was 9.60% per year.


Competitive Comparison of FDC's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, FDC's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FDC's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, FDC's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where FDC's 3-Year Revenue Growth Rate falls into.



FDC 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


FDC  (NSE:FDC) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


FDC 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of FDC's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


FDC (NSE:FDC) Business Description

Industry
Traded in Other Exchanges
Address
C-3 Skyvistas, Near Versova Police Station, D.N. Nagar, Andheri (West), Mumbai, MH, IND, 400053
FDC Ltd is an Indian-based pharmaceutical company with USFDA and UK-MHRA-approved API and formulations manufacturing facilities. It has its presence in numerous therapeutic segments: Anti-infectives, Gastro-Intestinal, Vitamins/Minerals/Nutrients, Ophthalmology/Otologicals, Cardiac, Dermatology, Respiratory, Gynaecology, and Others. The company's brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm. The majority of the revenue is generated domestically.

FDC (NSE:FDC) Headlines

From GuruFocus

Leon Cooperman on Surviving Fame and Infamy

By Robert Abbott Robert Abbott 01-31-2018

Value Stocks? Really?

By Mark Yu Mark Yu 04-06-2016

Steve Mandel Starts 3 New Positions in 3rd Quarter

By Sydnee Gatewood Sydnee Gatewood 11-29-2018

Leon Cooperman Buys 15.4 Million Shares of First Data

By David Goodloe David Goodloe 02-19-2016